- Home
- MDIA vs ZLAB Comparison
MDIA vs ZLAB Comparison
Compare MDIA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- ZLAB
- Stock Information
- Founded
- MDIA 2019
- ZLAB 2013
- Country
- MDIA United States
- ZLAB China
- Employees
- MDIA N/A
- ZLAB N/A
- Industry
- MDIA Broadcasting
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- MDIA Consumer Discretionary
- ZLAB Health Care
- Exchange
- MDIA Nasdaq
- ZLAB Nasdaq
- Market Cap
- MDIA 51.8M
- ZLAB 3.5B
- IPO Year
- MDIA N/A
- ZLAB 2017
- Fundamental
- Price
- MDIA $0.92
- ZLAB $29.24
- Analyst Decision
- MDIA
- ZLAB Buy
- Analyst Count
- MDIA 0
- ZLAB 4
- Target Price
- MDIA N/A
- ZLAB $47.37
- AVG Volume (30 Days)
- MDIA 34.7K
- ZLAB 1.2M
- Earning Date
- MDIA 05-19-2025
- ZLAB 05-08-2025
- Dividend Yield
- MDIA N/A
- ZLAB N/A
- EPS Growth
- MDIA N/A
- ZLAB N/A
- EPS
- MDIA N/A
- ZLAB N/A
- Revenue
- MDIA $95,571,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- MDIA N/A
- ZLAB $44.43
- Revenue Next Year
- MDIA N/A
- ZLAB $48.68
- P/E Ratio
- MDIA N/A
- ZLAB N/A
- Revenue Growth
- MDIA 195.05
- ZLAB 43.72
- 52 Week Low
- MDIA $0.92
- ZLAB $15.65
- 52 Week High
- MDIA $5.73
- ZLAB $39.77
- Technical
- Relative Strength Index (RSI)
- MDIA 39.71
- ZLAB 42.71
- Support Level
- MDIA $0.79
- ZLAB $27.61
- Resistance Level
- MDIA $1.00
- ZLAB $32.02
- Average True Range (ATR)
- MDIA 0.09
- ZLAB 1.23
- MACD
- MDIA -0.02
- ZLAB -0.18
- Stochastic Oscillator
- MDIA 32.92
- ZLAB 23.41
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.